Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly

By Jasmin Boyce · March 15, 2022, 7:49 PM EDT

A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Case Number

1:21-cv-10954

Court

Massachusetts

Nature of Suit

Patent

Date Filed

June 07, 2021